Clinical Pharmacy

CP-167

RENAL DONOR OR RECRUDESCENCE AS ORIGIN OF MALARIA INFECTION

CP-165

IMPACT ON HOSPITAL READMISSION OF MEDICATION RECONCILIATION IN POST EMERGENCY GERIATRIC UNIT : A PILOT STUDY

CP-164

AN AUDIT OF SELF-ADMINISTRATION OF MEDICINES IN CARDIOVASCULAR WARDS AND PATIENT'S PREFERENCE FOR MEDICINES ADMINISTRATION WHILE AN INPATIENT

CP-163

ONCO-HEMATOLOGICAL OUTPATIENTS TREATED WITH ORAL ANTINEOPLASTIC AGENTS: PHARMACIST INTERVENTIONS

CP-161

A CLINICAL AND COST ANALYSIS OF MEDICATION RECONCILIATION BY PHARMACISTS AT THE POINT OF HOSPITAL DISCHARGE

CP-160

CARBAPENEM DE-ESCALATION THERAPY FOR INTRA-ABDOMINAL INFECTION.

CP-155

PREVALENCE AND EFFECTIVINESS OF ANTIRETROVIRAL TREATMENT COMBINATIONS USED IN HIV PATIENTS NOT COLLECTED IN GUIDELINES

CP-153

LIRAGLUTIDE ADEQUACY AND EFFECTIVENESS IN REAL PRACTICE TYPE 2 DIABETES THERAPY

CP-151

ASSESSMENT OF AN EXPERIMENTAL CALL CENTER DEDICATED TO DRUG INFORMATION FOR OUTPATIENTS

CP-148

ACUTE CONFUSIONAL STATE: CASE REPORT

CP-147

A MEDICATION THERAPY MANAGEMENT PROGRAM FOR CHRONIC PATIENT : ABOUT PATIENT SATISFACTION IN CARDIOLOGY

CP-145

QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTS: EXPERIENCE IN A UNIVERSITY HOSPITAL OUTPATIENT PHARMACY

CP-144

FIRSTLINE TRIPLET OR DOUBLET CHEMOTHERAPY FOR HER2 NEGATIVE ADVANCED OESOPHAGOGASTRIC CANCER: AN ANALYSIS FROM A COMMUNITY PRACTICE REGISTRY

CP-140

ANALYSIS OF DISTRIBUTION AND ACCEPTABILITY OF PHARMACEUTICAL INTERVENTIONS AFTER IMPLANTATION OF THE ELECTRONIC ASSISTED PRESCRIPTION

CP-138

SPIRONOLACTONE IN PAEDIATRICS. TOXICITY UPDATE.

Pages